CRHR1 and neoplasm: Given recent findings for the anti-tumor properties of CRF2 agonists [30] and the lack of CRF2 expression on breast cancer cells one may suggest that inhibition of CRF1 and activation of CRF2 may successfully inhibit tumor growth.